Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Cipla Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500087
ISIN Demat	INE059A01026
Book Value	397.42

NSE Code	CIPLA
Dividend Yield %	1.06
Market Cap	1214564.34

P/E	23.55
EPS	63.86
Face Value	2


	BSE		NSE

06-Jun-2025

Last Price	1503.75
Net Change	14.1
% Change	0.95%
Prev.Close	1489.65
Open	1490.50
High	1505.80
Low	1484.00
Volume	27785

Last Price	1504.20
Net Change	14.4
% Change	0.97%
Prev.Close	1489.80
Open	1489.80
High	1505.90
Low	1484.00
Volume	861882

Value	41542991
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1505.80
52-Week High	1702.00
52-Week Low	1310.05

Value	1290308227.1
Best Buy	1504.20
Best Sell	0.00
Best Quantity	6
Sell Quantity	0
Today's Range	1505.90
52-Week High	1702.05
52-Week Low	1335.00

Open Price	1499.30
High Price	1509.40
Low Price	1490.10
Last Price	1508.10
Prev Close	1496.90
Change	11.20
% Change	0.75 %

Average Price	1501.17
Underlying Value	1504.20
Number of contracts traded	2974
Turnover in Rs. Lakhs	14510
Open Interest	11442600.00
Change in O I	-184930.00
% Change in O I	-1.59 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	6
Price	1504.20

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	325
Price	1507.2

Quantity	325
Price	1508.4

Holding Details

Latest Corporate Events

Bonus

3 : 2

24-Apr-06

Book Closure

11-Aug-21

25-Aug-21

Dividend

150 %

27-Jun-25

Company News

31-05-2025

USFDA concludes cGMP insp...

30-05-2025

Cipla’s arm acquires 26% ...

30-05-2025

Cipla rises as its arm ac...

30-05-2025

Cipla’s arm incorporates ...

20-05-2025

Cipla’s arm inks pact to ...

19-05-2025

Cipla’s arm’s Mahape faci...

13-05-2025

Cipla reports 30% rise in...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.